J. Feng
2 Papers
J. Feng is an academic researcher. The author has contributed to research in topics: Internal medicine & Metastatic breast cancer. The author has an hindex of 1, co-authored 2 publications.
Chat about Author
Papers
Snowmass2021 Cosmic Frontier: The landscape of low-threshold dark matter direct detection in the next decade
Rouven Essig,G. K. Giovanetti,Noah Kurinsky,Daniel McKinsey,Karthik Ramanathan,K. Stifter,Tien-Tien Yu,Amin Aboubrahim,D. Adams,Daniele S. M. Alves,T. Aralis,H. Ara'ujo,D. Baxter,Kim V. Berghaus,Asher Berlin,Carlos Blanco,I. Bloch,W. Bonivento,R. Bunker,Sergey Burdin,A. Caminata,M. C. Carmona-Benitez,Luke Chaplinsky,Thomas Chen,Stephen E. Derenzo,L. de Viveiros,Rainer Dick,N. Di Marco,Peizhi Du,Baishali Dutta,Reza Ebadi,Timon Emken,Antonio Esposito,Erez Etzion,J. Feng,Nicolas Fernandez,Shao-Feng Ge,S. Ghosh,G. Giroux,L. Hamaide,S. A. Hertel,Gonzalo Herrera,Yonit Hochberg,Y. Kahn,Bradley J. Kavanagh,A. N. Khan,H. Kluck,S. Kravitz,B. von Krosigk,Jason Kumar,I. Lawson,Benjamin V. Lehmann,Ting Li,Junhui Liao,Stephanie A. Lyon,Peter Majewski,Claudio Andrea Manzari,Jocelyn Monroe,M. E. Monzani,David J. Morrissey,D. Norcini,A. Orly,A. Parikh,J. Park,P. Patel,S Paul,A. Phipps,A. Pocar,Auguste Ritz,Y. Sarkis,Philip Schuster,Thomas Schwetz,S. Shaw,S. Shin,Aman Singal,R. P. Singh,Oren Slone,P. Sorensen,C. Sun,Matthew Szydagis,D. Temples,G. Testera,Kurt Dipl Ing Thieme,Natalia Toro,Tanner Trickle,Sho Uemura,V. Velan,Edoardo Vitagliano,Friedrich Wagner,Gang Wang,S. Westerdale,Kathryn M. Zurek +91 more
- 15 Mar 2022
TL;DR: The search for particle-like dark matter with meV-to-GeV masses has developed rapidly in the past few years as mentioned in this paper , and the science case for these searches, the recent progress, and the exciting upcoming opportunities.
55
9P Prognostic value of baseline neutrophil/lymphocyte ratio in HER2-positive metastatic breast cancer: Exploratory analysis from the CLEOPATRA trial
Z. Xiao,Nianhua Ding,Jiushen Pang,X. Liu,X. He,W. J. Zhou,H. Xie,J. Feng,G. Wang,L He,Y. He,S. Wang +11 more
TL;DR: In this article , the authors evaluated the role of baseline neutrophil/lymphocyte ratio (NLR) for HER2-positive MBC patients treated with trastuzumab/pertuzumaab.